The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicenter, open-label, uncontrolled phase II study of ONO-4538 for cutaneous angiosarcoma (Angio Check study).
 
Yasuhiro Fujisawa
Consulting or Advisory Role - Lilly
Speakers' Bureau - Bristol-Myers Squibb Japan; MSD; Novartis; Ono Pharmaceutical
Research Funding - Eisai
 
Koji Yoshino
Speakers' Bureau - MSD; Novartis; Ono Pharmaceutical
 
Taiki Isei
Honoraria - Bristol-Myers Squibb; Ono Pharmaceutical
Consulting or Advisory Role - Ono Pharmaceutical; Pfizer
 
Kenjiro Namikawa
Honoraria - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Ono Pharmaceutical; Toray Industries
 
Taku Fujimura
No Relationships to Disclose
 
Masahito Yasuda
Speakers' Bureau - Abbvie; Janssen; Kyowa Kirin; Lilly; Maruho; Novartis; Taiho Pharmaceutical
 
Yuki Yamamoto
No Relationships to Disclose
 
Hiroshi Uchi
No Relationships to Disclose
 
Teruki Yanagi
No Relationships to Disclose
 
Hiroshi Kato
Speakers' Bureau - Ono Pharmaceutical
 
Atsushi Otsuka
Research Funding - Eisai